Minimal clinically important differences for the EQ-5D and QWB-SA in Post-traumatic Stress Disorder (PTSD): results from a Doubly Randomized Preference Trial (DRPT)
Open Access
- 1 January 2013
- journal article
- research article
- Published by Springer Nature in Health and Quality of Life Outcomes
- Vol. 11 (1) , 59
Abstract
To determine the minimal clinically important difference (MCID) for the health-utility measures EuroQol-5 dimensions (EQ-5D) and Quality of Well Being Self-Administered (QWB-SA) Scale in PTSD patients. Two hundred patients aged 18 to 65 years with PTSD enrolled in a doubly randomized preference trial (DRPT) examining the treatment and treatment-preference effects between cognitive behavioral therapy and pharmacotherapy with sertraline and completed the EQ-5D and QWB-SA at baseline and 10-week post-treatment. The anchor-based methods utilized a Clinical Global Impression-Improvement (CGI-I) and Clinical Global Impression-Severity. We regressed the changes in EQ-5D and QWB-SA scores on changes in the anchors using ordinary least squares regression. The slopes (beta coefficients) were the rates of change in the anchors as functions of change in EQ-5D and QWB, which represent our estimates of MCID. In addition, we performed receiver operating characteristic (ROC) curve analysis to examine the relationship between the changes in EQ-5D and QWB-SA scores and treatment-response status. The MCIDs were estimated from the ROC curve where they best discriminate between treatment responders and non-responders. The distribution-based methods used small to moderate effect size in terms of 0.2 and 0.5 of standard deviation of the pre-treatment EQ-5D and QWB-SA scores. The anchor-based methods estimated the MCID ranges of 0.05 to 0.08 for the EQ-5D and 0.03 to 0.05 for the QWB. The MCID ranges were higher with the distribution-based methods, ranging from 0.04 to 0.10 for the EQ-5D and 0.02 to 0.05 for the QWB-SA. The established MCID ranges of EQ-5D and QWB-SA can be a useful tool in assessing meaningful changes in patient's quality of life for researchers and clinicians, and assisting health-policy makers to make informing decision in mental health treatment. Clinicaltrials.gov; Identifier: NCT00127673.Keywords
This publication has 35 references indexed in Scilit:
- Posttraumatic stress symptoms and health-related quality of life: a two year follow up study of injury treated at the emergency departmentBMC Psychiatry, 2012
- Predictors of Health-Related Quality-of-Life Utilities Among Persons With Posttraumatic Stress DisorderPsychiatric Services, 2011
- A Longitudinal Comparison of 5 Preference-Weighted Health State Classification Systems in Persons with Intervertebral Disk HerniationMedical Decision Making, 2010
- Posttraumatic Stress Disorder and Health-Related Quality of Life in Patients With Coronary Heart DiseaseArchives of General Psychiatry, 2009
- Evaluation of the meaningfulness of health‐related quality of life improvements as assessed by the SF‐36 and the EQ‐5D VAS in patients with active Crohn’s diseaseAlimentary Pharmacology & Therapeutics, 2009
- Estimation of minimally important differences in EQ-5D utility and VAS scores in cancerHealth and Quality of Life Outcomes, 2007
- Quality of Life in Individuals With Anxiety DisordersAmerican Journal of Psychiatry, 2000
- Methods for defining and determining the clinical significance of treatment effects: Description, application, and alternatives.Journal of Consulting and Clinical Psychology, 1999
- Psychometric properties of the PTSD checklist (PCL)Behaviour Research and Therapy, 1996
- Reproducibility and responsiveness of health status measures statistics and strategies for evaluationControlled Clinical Trials, 1991